Sarepta Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Sarepta Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Sarepta Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Sarepta Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $4.5M | 234k | 19.27 |
| 2025-06-30 | $6.8M | 396k | 17.10 |
| 2025-03-31 | $30M | 463k | 63.82 |
| 2024-12-31 | $36M | 299k | 121.59 |
| 2024-09-30 | $34M | 268k | 124.89 |
| 2024-06-30 | $48M | 302k | 158.00 |
| 2024-03-31 | $21M | 161k | 129.46 |
| 2023-12-31 | $16M | 161k | 96.43 |
| 2023-09-30 | $20M | 161k | 121.22 |
| 2023-06-30 | $22M | 157k | 137.83 |
| 2023-03-31 | $22M | 157k | 137.83 |
| 2022-12-31 | $16M | 121k | 129.58 |
| 2022-09-30 | $13M | 120k | 110.54 |
| 2022-06-30 | $10M | 139k | 74.96 |
| 2022-03-31 | $11M | 138k | 78.12 |
| 2021-12-31 | $15M | 165k | 90.05 |
| 2021-09-30 | $9.4M | 102k | 92.48 |
| 2021-06-30 | $8.7M | 112k | 77.74 |
| 2021-03-31 | $15M | 205k | 74.53 |
| 2020-12-31 | $56M | 396k | 140.43 |
| 2020-09-30 | $56M | 396k | 140.43 |
| 2020-06-30 | $63M | 396k | 160.34 |
| 2020-03-31 | $45M | 456k | 97.82 |
| 2019-12-31 | $58M | 452k | 129.04 |
| 2019-09-30 | $30M | 393k | 75.32 |
| 2019-06-30 | $45M | 297k | 151.95 |
| 2019-03-31 | $30M | 254k | 119.19 |
| 2018-12-31 | $27M | 244k | 109.13 |
| 2018-09-30 | $36M | 223k | 161.51 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas